Skip to main navigation
Skip to search
Skip to main content
the UWA Profiles and Research Repository Home
Login
Home
Profiles
Organisations
Research output
Grants
Datasets
Prizes / Awards
Engagement / Activities
Press/Media
Units
Equipment
Impacts
Search by expertise, name or affiliation
Lipid-lowering trials in the primary and secondary prevention of coronary heart disease: new evidence, implications and outstanding issues
Gerald Watts
, Valerie Burke
Research output
:
Contribution to journal
›
Literature review
49
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Lipid-lowering trials in the primary and secondary prevention of coronary heart disease: new evidence, implications and outstanding issues'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Cholesterol
100%
Lipid
100%
Secondary Prevention
100%
Coronary Artery Disease
100%
Pravastatin
100%
Primary Prevention
100%
Cardiovascular System
50%
Triacylglycerol
50%
Atherosclerosis
50%
Carotid Artery
50%
Low Density Lipoprotein Cholesterol
50%
Ischemic Heart Disease
50%
High Density Lipoprotein Cholesterol
50%
Drug Therapy
50%
Statin
50%
Hypercholesterolemia
50%
Familial Hypercholesterolemia
50%
Bezafibrate
50%
Regression of Coronary Artery Disease
50%
LDL Apheresis
50%
Cholesterol Screening
50%
Chemistry
Cholesterol
100%
Lipid
40%
Pravastatin
40%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
20%
Triglyceride
20%
Bezafibrate
20%